Carl K. Gjertson, MD Department of Urology, College of Physicians and Surgeons, Columbia University, New York
Konstantin Walmsley, MD Department of Urology, College of Physicians and Surgeons, Columbia University, New York
Steven A. Kaplan, MD Department of Urology, College of Physicians and Surgeons, Columbia University, New York
Address: Steven A. Kaplan, MD, Department of Urology, College of Physicians and Surgeons, Columbia University, Irving Pavilion, 11th floor, 161 Fort Washington Avenue, New York, NY 10032; e-mail sk46@columbia.edu
Dr. Kaplan has indicated that he has received grant or research support from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, and that he is on the speakers’ bureaus of the Merck, Glaxo, Boehringer Ingelheim, and Sanofi corporations.
ABSTRACTOur treatment strategies for benign prostatic hyperplasia (BPH) have changed, with new insights into the pathophysiology of the disease, new clinical trials, and surgical advances. We present an update on treatment options and a diagnostic and treatment algorithm for this condition.
